Vitamin E Forms in Alzheimer's Disease: A Review of Controversial and Clinical Experiences

REFERENCES

• Ames, B. N., Shigenaga, M. K., and Hagen, T. M., 1993. Oxidants, antioxidants, and the degenerative diseases of aging., Proc Natl Acad Sci. 90 (17) (1993), pp. 7915–7922.
   PubMed Web of Science ®Google Scholar
• Aydemir, O., Celebi, S., Yilmaz, T., Yekeler, H., and Kukner, A. S., 2004. Protective effects of vitamin E forms (alpha-tocopherol, gamma-tocopherol and d-alpha-tocopherol polyethylene glycol 1000 succinate) on retinal edema during ischemia-reperfusion injury in the guinea pig retina, Int Ophthalmol. 25 (5–6) (2004), pp. 283–289.
   PubMedGoogle Scholar
• Baker, H., Handelman, G. J., Short, S., Machlin, L. J., Bhagavan, H. N., Dratz, E. A., and Frank, O., 1986. Comparison of plasma alpha and gamma tocopherol levels following chronic oral administration of either all-rac-alpha-tocopheryl acetate or RRR-alpha-tocopheryl acetate in normal adult male subjects, Am J Clin Nutr. 43 (3) (1986), pp. 382–387.
   PubMed Web of Science ®Google Scholar
• Burton, G. W., Joyce, A., and Ingold, K. U., 1983. Is vitamin E the only lipid-soluble, chain-breaking antioxidant in human blood plasma and erythrocyte membranes?, Arch Biochem Biophys. 221 (1) (1983), pp. 281–290.
   PubMed Web of Science ®Google Scholar
• Butterfield, D. A., Castegna, A., Drake, J., Scapagnini, G., and Calabrese, V., 2002. Vitamin E and neurodegenerative disorders associated with oxidative stress, Nutr Neurosci. 5 (4) (2002), pp. 229–239.
   PubMed Web of Science ®Google Scholar
• Canevari, L., Abramov, A. Y., and Duchen, M. R., 2004. Toxicity of amyloid beta peptide: tales of calcium, mitochondria, and oxidative stress, Neurochem Res. 29 (3) (2004), pp. 637–650.
   PubMed Web of Science ®Google Scholar
• Christen, S., Woodall, A. A., Shigenaga, M. K., Southwell-Keely, P. T., Duncan, M. W., and Ames, B. N., 1997. gamma-tocopherol traps mutagenic electrophiles such as NO(X) and complements alpha-tocopherol: physiological implications, Proc Natl Acad Sci. 94 (7) (1997), pp. 3217–3222.
   PubMed Web of Science ®Google Scholar
• Clarke, M. W., Ward, N. C., Wu, J. H., Hodgson, J. M., Puddey, I. B., and Croft, K. D., 2006. Supplementation with mixed tocopherols increases serum and blood cell gamma-tocopherol but does not alter biomarkers of platelet activation in subjects with type 2 diabetes, Am J Clin Nutr. 83 (1) (2006), pp. 95–102.
   PubMed Web of Science ®Google Scholar
• Cooney, R. V., Franke, A. A., Harwood, P. J., Hatch-Pigott, V., Custer, L. J., and Mordan, L. J., 1993. Gamma-tocopherol detoxification of nitrogen dioxide: superiority to alpha-tocopherol, Proc Natl Acad Sci. 90 (5) (1993), pp. 1771–1775.
   PubMed Web of Science ®Google Scholar
• Coyle, J. T., and Puttfarcken, P., 1993. Oxidative stress, glutamate, and neurodegenerative disorders, Science. 262 (5134) (1993), pp. 689–695.
   PubMed Web of Science ®Google Scholar
• Elmadfa, I., and Park, E., 1999. Impact of diets with corn oil or olive/sunflower oils on DNA damage in healthy young men, Eur J Nutr. 38 (6) (1999), pp. 286–292.
   PubMed Web of Science ®Google Scholar
• Engelhart, M. J., Geerlings, M. I., Ruitenberg, A., van Swieten, J. C., Hofman, A., Witteman, J. C., and Breteler, M. M., 2002. Dietary intake of antioxidants and risk of Alzheimer disease, Jama. 287 (24) (2002), pp. 3223–3229.
   PubMed Web of Science ®Google Scholar
• Evans, P. H., 1993. Free radicals in brain metabolism and pathology, Br Med Bull. 49 (3) (1993), pp. 577–587.
   PubMed Web of Science ®Google Scholar
• Floyd, R. A., and Hensley, K., 2002. Oxidative stress in brain aging. Implications for therapeutics of neurodegenerative diseases, Neurobiol Aging. 23 (5) (2002), pp. 795–807.
   PubMed Web of Science ®Google Scholar
• 2000. Dietary reference intakes for vitamin C, vitamin E, selenium, and carotenoids. Washington DC: National Acaedemy Press; 2000, Food and Nutrition Board, I. o. M. ed..
   Google Scholar
• Gackowski, D., Rozalski, R., Siomek, A., Dziaman, T., Nicpon, K., Klimarczyk, M., Araszkiewicz, A., and Olinski, R., 2008. Oxidative stress and oxidative DNA damage is characteristic for mixed Alzheimer disease/vascular dementia, J Neurol Sci. 266 (1–2) (2008), pp. 57–62.
   PubMed Web of Science ®Google Scholar
• Halliwell, B., 1999. Antioxidant defence mechanisms: from the beginning to the end (of the beginning), Free Radic Res. 31 (4) (1999), pp. 261–272.
   PubMed Web of Science ®Google Scholar
• Handelman, G. J., Epstein, W. L., Peerson, J., Spiegelman, D., Machlin, L. J., and Dratz, E. A., 1994. Human adipose alpha-tocopherol and gamma-tocopherol kinetics during and after 1 y of alpha-tocopherol supplementation, Am J Clin Nutr. 59 (5) (1994), pp. 1025–1032, .
   PubMed Web of Science ®Google Scholar
• Handelman, G. J., Machlin, L. J., Fitch, K., Weiter, J. J., and Dratz, E. A., 1985. Oral alpha-tocopherol supplements decrease plasma gamma-tocopherol levels in humans, J Nutr. 115 (6) (1985), pp. 807–813.
   PubMed Web of Science ®Google Scholar
• Helzlsouer, K. J., Huang, H. Y., Alberg, A. J., Hoffman, S., Burke, A., Norkus, E. P., Morris, J. S., and Comstock, G. W., 2000. Association between alpha-tocopherol, gamma-tocopherol, selenium, and subsequent prostate cancer, J Natl Cancer Inst. 92 (24) (2000), pp. 2018–2023.
   PubMed Web of Science ®Google Scholar
• Huang, H. Y., Alberg, A. J., Norkus, E. P., Hoffman, S. C., Comstock, G. W., and Helzlsouer, K. J., 2003. Prospective study of antioxidant micronutrients in the blood and the risk of developing prostate cancer, Am J Epidemiol. 157 (4) (2003), pp. 335–344.
   PubMed Web of Science ®Google Scholar
• Huang, H. Y., and Appel, L. J., 2003. Supplementation of diets with alpha-tocopherol reduces serum concentrations of gamma- and delta-tocopherol in humans, J Nutr. 133 (10) (2003), pp. 3137–3140.
   PubMed Web of Science ®Google Scholar
• Jenner, P., 1994. Oxidative damage in neurodegenerative disease, Lancet. 344 (8925) (1994), pp. 796–798.
   PubMed Web of Science ®Google Scholar
• Jenner, P., 2003. Oxidative stress in Parkinson's disease, Ann Neurol. 53 (Suppl 3) (2003), pp. S26–36, discussion S36–28.
   PubMed Web of Science ®Google Scholar
• Jiang, Q., Elson-Schwab, I., Courtemanche, C., and Ames, B. N., 2000. gamma-tocopherol and its major metabolite, in contrast to alpha-tocopherol, inhibit cyclooxygenase activity in macrophages and epithelial cells, Proc Natl Acad Sci. 97 (21) (2000), pp. 11494–11499.
   PubMed Web of Science ®Google Scholar
• Kamal-Eldin, A., and Appelqvist, L. A., 1996. The chemistry and antioxidant properties of tocopherols and tocotrienols, Lipids. 31 (7) (1996), pp. 671–701.
   PubMed Web of Science ®Google Scholar
• Knight, J. A., 1997. Reactive oxygen species and the neurodegenerative disorders, Ann Clin Lab Sci. 27 (1) (1997), pp. 11–25.
   PubMed Web of Science ®Google Scholar
• Lodge, J. K., Ridlington, J., Leonard, S., Vaule, H., and Traber, M. G., 2001. Alpha- and gamma-tocotrienols are metabolized to carboxyethyl-hydroxychroman derivatives and excreted in human urine, Lipids. 36 (1) (2001), pp. 43–48.
   PubMed Web of Science ®Google Scholar
• Martin, A., Janigian, D., Shukitt-Hale, B., Prior, R. L., and Joseph, J. A., 1999. Effect of vitamin E intake on levels of vitamins E and C in the central nervous system and peripheral tissues: implications for health recommendations, Brain Res. 845 (1) (1999), pp. 50–59.
   PubMed Web of Science ®Google Scholar
• McIntyre, B. S., Briski, K. P., Gapor, A., and Sylvester, P. W., 2000. Antiproliferative and apoptotic effects of tocopherols and tocotrienols on preneoplastic and neoplastic mouse mammary epithelial cells, Proc Soc Exp Biol Med. 224 (4) (2000), pp. 292–301.
   PubMed Web of Science ®Google Scholar
• McLaughlin, P. J., and Weihrauch, J. L., 1979. Vitamin E content of foods, J Am Diet Assoc. 75 (6) (1979), pp. 647–665.
   PubMed Web of Science ®Google Scholar
• Mirra, S., 1997. Alzheimer's Disease and Other Dementias: Neuropathological Considerations. Washington, DC: American Psychiatric Publishing, Inc; 1997.
   Google Scholar
• Morris, M. C., Evans, D. A., Bienias, J. L., Tangney, C. C., and Wilson, R. S., 2002. Vitamin E and cognitive decline in older persons, Arch Neurol. 59 (7) (2002), pp. 1125–1132.
   PubMed Web of Science ®Google Scholar
• Mortimer, J., 1997. Is Alzheimer's Disease a Lifelong Illness? Risk Factors for Pathological and Clinical Disease. Washington, DC: American Psychiatric Publishing, Inc; 1997.
   Google Scholar
• Moyad, M. A., Brumfield, S. K., and Pienta, K. J., 1999. Vitamin E, alpha- and gamma-tocopherol, and prostate cancer, Semin Urol Oncol. 17 (2) (1999), pp. 85–90.
   PubMedGoogle Scholar
• Petersen, R. C., Thomas, R. G., Grundman, M., Bennett, D., Doody, R., Ferris, S., Galasko, D., Jin, S., Kaye, J., Levey, A., Pfeiffer, E., Sano, M., van Dyck, C. H., and Thal, L. J., 2005. Vitamin E and donepezil for the treatment of mild cognitive impairment, N Engl J Med. 352 (23) (2005), pp. 2379–2388.
   PubMed Web of Science ®Google Scholar
• Puglielli, L., Tanzi, R. E., and Kovacs, D. M., 2003. Alzheimer's disease: the cholesterol connection, Nat Neurosci. 6 (4) (2003), pp. 345–351.
   PubMed Web of Science ®Google Scholar
• Ricciarelli, R., Argellati, F., Pronzato, M. A., and Domenicotti, C., 2007. Vitamin E and neurodegenerative diseases, Mol Aspects Med. 28 (5–6) (2007), pp. 591–606.
   PubMed Web of Science ®Google Scholar
• Rinaldi, P., Polidori, M. C., Metastasio, A., Mariani, E., Mattioli, P., Cherubini, A., Catani, M., Cecchetti, R., Senin, U., and Mecocci, P., 2003. Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer's disease, Neurobiol Aging. 24 (7) (2003), pp. 915–919.
   PubMed Web of Science ®Google Scholar
• Rota, C., Rimbach, G., Minihane, A. M., Stoecklin, E., and Barella, L., 2005. Dietary vitamin E modulates differential gene expression in the rat hippocampus: potential implications for its neuroprotective properties, Nutr Neurosci. 8 (1) (2005), pp. 21–29.
   PubMed Web of Science ®Google Scholar
• Saldeen, T., Li, D., and Mehta, J. L., 1999. Differential effects of alpha- and gamma-tocopherol on low-density lipoprotein oxidation, superoxide activity, platelet aggregation and arterial thrombogenesis, J Am Coll Cardiol. 34 (4) (1999), pp. 1208–1215.
   PubMed Web of Science ®Google Scholar
• Sano, M., Ernesto, C., Thomas, R. G., Klauber, M. R., Schafer, K., Grundman, M., Woodbury, P., Growdon, J., Cotman, C. W., Pfeiffer, E., Schneider, L. S., and Thal, L. J., 1997. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study, N Engl J Med. 336 (17) (1997), pp. 1216–1222.
   PubMed Web of Science ®Google Scholar
• Selkoe, D. J., 2005. Defining molecular targets to prevent Alzheimer disease, Arch Neurol. 62 (2) (2005), pp. 192–195.
   PubMed Web of Science ®Google Scholar
• Sies, H., 2007. Biological redox systems and oxidative stress, Cell Mol Life Sci. 64 (17) (2007), pp. 2181–2188.
   PubMed Web of Science ®Google Scholar
• Smith, M. A., Rottkamp, C. A., Nunomura, A., Raina, A. K., and Perry, G., 2000. Oxidative stress in Alzheimer's disease, Biochim Biophys Acta. 1502 (1) (2000), pp. 139–144.
   PubMed Web of Science ®Google Scholar
• St George-Hyslop, P. H., 2000. Piecing together Alzheimer's, Sci Am. 283 (6) (2000), pp. 76–83.
   PubMed Web of Science ®Google Scholar
• Wagner, K. H., Kamal-Eldin, A., and Elmadfa, I., 2004. Gamma-tocopherol–an underestimated vitamin?, Ann Nutr Metab. 48 (3) (2004), pp. 169–188.
   PubMed Web of Science ®Google Scholar
• Williamson, K. S., Gabbita, S. P., Mou, S., West, M., Pye, Q. N., Markesbery, W. R., Cooney, R. V., Grammas, P., Reimann-Philipp, U., Floyd, R. A., and Hensley, K., 2002. The nitration product 5-nitro-gamma-tocopherol is increased in the Alzheimer brain, Nitric Oxide. 6 (2) (2002), pp. 221–227.
   PubMed Web of Science ®Google Scholar